
|Articles|December 1, 2003
FDA Panel Gives Nod to Wrinkle Fighters
Washington - The FDA advisory panel reviewing Hylaform and Restylane, the newest upstarts in the battle against wrinkles and scars, recommended each for approval, with conditions, by a 6-3 vote November 21.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
FDA Accepts Addition of Bemotrizinol as First New Sunscreen Ingredient in 20 Years
2
Once-Daily Zasocitinib Rivals Injectable Biologics for Skin Clearance, Phase 3 Data Show
3
Moving Past Dermal Filler Trends to Focus on Healthy Skin Aging
4
Filling the HS Treatment Gap: Ruxolitinib Targets Early-Stage Disease
5














